Guizhou Bailing Group Pharmaceutical Co Ltd (002424) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.090x

Based on the latest financial reports, Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a cash flow conversion efficiency ratio of 0.090x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.76 Million ≈ $43.13 Million USD) by net assets (CN¥3.28 Billion ≈ $480.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Guizhou Bailing Group Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Guizhou Bailing Group Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Guizhou Bailing Group Pharmaceutical Co total liabilities for a breakdown of total debt and financial obligations.

Guizhou Bailing Group Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Bailing Group Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Otokar Otomotiv ve Savunma Sanayi AS
IS:OTKAR
-0.203x
Coursera Inc
NYSE:COUR
0.009x
Liquidity Services Inc
NASDAQ:LQDT
-0.002x
Cansino Biologics Inc
SHG:688185
0.006x
Hunan New Wellful Co Ltd
SHG:600975
0.064x
Lindblad Expeditions Holdings Inc
NASDAQ:LIND
-0.152x
Caisse Régionale de Crédit Agricole Mutuel de Paris et d-Ile-de-France
PA:CAF
0.006x
Piedmont Office Realty Trust Inc
NYSE:PDM
0.040x

Annual Cash Flow Conversion Efficiency for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see Guizhou Bailing Group Pharmaceutical Co stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.20 Billion
≈ $468.14 Million
CN¥9.02 Million
≈ $1.32 Million
0.003x -92.09%
2023-12-31 CN¥3.53 Billion
≈ $516.15 Million
CN¥125.77 Million
≈ $18.40 Million
0.036x -71.62%
2022-12-31 CN¥4.00 Billion
≈ $584.87 Million
CN¥502.15 Million
≈ $73.48 Million
0.126x +53.13%
2021-12-31 CN¥3.96 Billion
≈ $579.50 Million
CN¥324.92 Million
≈ $47.55 Million
0.082x +38.77%
2020-12-31 CN¥3.92 Billion
≈ $573.66 Million
CN¥231.78 Million
≈ $33.92 Million
0.059x -47.68%
2019-12-31 CN¥4.14 Billion
≈ $605.25 Million
CN¥467.41 Million
≈ $68.40 Million
0.113x +381.70%
2018-12-31 CN¥3.92 Billion
≈ $574.31 Million
CN¥-157.45 Million
≈ $-23.04 Million
-0.040x -274.11%
2017-12-31 CN¥3.47 Billion
≈ $507.36 Million
CN¥79.88 Million
≈ $11.69 Million
0.023x -84.86%
2016-12-31 CN¥3.07 Billion
≈ $448.56 Million
CN¥466.62 Million
≈ $68.28 Million
0.152x -1.24%
2015-12-31 CN¥2.68 Billion
≈ $392.31 Million
CN¥413.23 Million
≈ $60.47 Million
0.154x -8.57%
2014-12-31 CN¥2.35 Billion
≈ $343.57 Million
CN¥395.83 Million
≈ $57.92 Million
0.169x +153.01%
2013-12-31 CN¥2.13 Billion
≈ $311.30 Million
CN¥141.76 Million
≈ $20.74 Million
0.067x +597.39%
2012-12-31 CN¥2.04 Billion
≈ $298.89 Million
CN¥19.52 Million
≈ $2.86 Million
0.010x -90.82%
2011-12-31 CN¥1.94 Billion
≈ $283.94 Million
CN¥201.90 Million
≈ $29.54 Million
0.104x +142.93%
2010-12-31 CN¥1.85 Billion
≈ $270.28 Million
CN¥-447.68 Million
≈ $-65.51 Million
-0.242x -172.42%
2009-12-31 CN¥374.42 Million
≈ $54.79 Million
CN¥125.31 Million
≈ $18.34 Million
0.335x +317.54%
2008-12-31 CN¥262.75 Million
≈ $38.45 Million
CN¥-40.42 Million
≈ $-5.92 Million
-0.154x +64.59%
2007-12-31 CN¥182.68 Million
≈ $26.73 Million
CN¥-79.37 Million
≈ $-11.61 Million
-0.434x --

About Guizhou Bailing Group Pharmaceutical Co Ltd

SHE:002424 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.03 Billion
CN¥7.03 Billion CNY
Market Cap Rank
#8983 Global
#2390 in China
Share Price
CN¥5.03
Change (1 day)
-0.98%
52-Week Range
CN¥3.94 - CN¥6.65
All Time High
CN¥28.52
About

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines … Read more